People Living With HIV, Oral and Oropharyngeal Cancer, and Health Equity

Sponsor
University of California, San Francisco (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06055868
Collaborator
National Institute of Dental and Craniofacial Research (NIDCR) (NIH)
144
1
60
2.4

Study Details

Study Description

Brief Summary

This is an exploratory qualitative study among People Living With HIV (PLWH) of diverse racial/ethnic and sexual and gender minority (SGM) identities to explore individual, interpersonal, and structural oral health equity factors that serve as barriers or facilitators of accessing oral health care, knowledge and perceptions of human papillomavirus (HPV) vaccination and Oral squamous cell carcinoma (OSCC) /Oropharyngeal squamous cell carcinoma (OPSCC), and to collect recommendations on how to increase access to oral health care and engage PLWH in OSCC/OPSCC prevention.

Condition or Disease Intervention/Treatment Phase
  • Other: Group Meeting (Focus Group)
  • Other: Questionnaires

Detailed Description

OBJECTIVES:
  1. To identify individual, interpersonal, and structural oral health equity factors (e.g., internalized stigma; enacted stigma; transportation/hours) that serve as barriers or facilitators to accessing regular and appropriate oral health care, among PLWH of intersecting racial/ethnic and SGM groups.

  2. To explore knowledge and perceptions about causes, risk factors, prevention, and screening for OSCC/OPSCC and HPV vaccination and if identity group membership influences knowledge and perceptions of these issues.

  3. To elicit recommendations for improving access to regular and appropriate oral health care, and suggestions on how to engage PLWH from diverse identity groups in prevention interventions.

OUTLINE:

There will be one screening and enrollment phone call and only one study visit for the Focus Group Discussions (FDGs). A short quantitative survey will be administered.

Study Design

Study Type:
Observational
Anticipated Enrollment :
144 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
People Living With HIV (PLWH), Oral and Oropharyngeal Cancer, and Health Equity: A Qualitative Study
Anticipated Study Start Date :
Nov 30, 2024
Anticipated Primary Completion Date :
Nov 30, 2029
Anticipated Study Completion Date :
Nov 30, 2029

Arms and Interventions

Arm Intervention/Treatment
Qualitative Focus Group

Participants will be asked to a series of questions to help place them in a focus group with other individuals of shared identity and will also complete a short quantitative survey either emailed to the participant or the outreach worker/study coordinator will administer the survey by phone. Participants will then participate in one 1.5-2 hour, facilitated, focus group discussions (FGD).

Other: Group Meeting (Focus Group)
Focus Group Discussions (FDGs) will be recorded, transcribed, and coded.

Other: Questionnaires
Given electronically or via phone by study team staff

Outcome Measures

Primary Outcome Measures

  1. Identification of potential oral health equity factors [Up to 3 days]

    Participants will complete a baseline questionnaire which will aid in the formation of the focus group with other individuals of shared identity. The Focus Group Discussions (FGDs) will be transcribed, coded, and the focus group guide will be updated following the Grounded Theory qualitative research methodology. The "data" from the FGD are the audio recordings and the transcripts. The digital transcript of each focus group will be uploaded to the software MAXQDA to aid with coding and analysis in identifying individual, interpersonal, and structural factors, if any, that may impact accessing oral health care.

Other Outcome Measures

  1. Assess participant perceptions about OSCC/OPSCC and HPV vaccination [During focus group, 1 day]

    FGDs will be transcribed, coded, and the focus group guide will be updated following the Grounded Theory qualitative research methodology. The "data" from the FGD are the audio recordings and the transcripts. The digital transcript of each focus group will be uploaded to the software MAXQDA to aid with coding and analysis in assessing information on participant's perception of causes, risk factors, prevention, and screening for OSCC/OPSCC and HPV vaccination.

  2. Assess participant knowledge about OSCC/OPSCC and HPV vaccination [During focus group, 1 day]

    FGDs will be transcribed, coded, and the focus group guide will be updated following the Grounded Theory qualitative research methodology. The "data" from the FGD are the audio recordings and the transcripts. The digital transcript of each focus group will be uploaded to the software MAXQDA to aid with coding and analysis in assessing information on participant's knowledge of causes, risk factors, prevention, and screening for OSCC/OPSCC and HPV vaccination

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants must be 18-years old or older.

  • Participants must be individuals living with HIV

  • Ability to speak and understand English

  • Identify as one or more racial/ethnic minority groups or sexual and gender minority groups

  • All genders and members of all races and ethnic groups are eligible for this study.

Exclusion Criteria:
  • Younger than 18-years old.

  • Not living with HIV.

  • Not able to speak and understand English.

  • Not classified as one or more racial/ethnic minority groups or sexual and gender minority groups.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of California, San Francisco San Francisco California United States 94143

Sponsors and Collaborators

  • University of California, San Francisco
  • National Institute of Dental and Craniofacial Research (NIDCR)

Investigators

  • Principal Investigator: Alexandra Hernandez, PhD, MPH, University of California, San Francisco

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT06055868
Other Study ID Numbers:
  • 23363
  • R03DE032972
First Posted:
Sep 28, 2023
Last Update Posted:
Sep 28, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University of California, San Francisco
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 28, 2023